Cervical Cancer part 2 : Obstetrics and gynaecology Video lectures ( Medvizz app )
๐๐
๐จ๐ฅ๐ฅ๐จ๐ฐ ๐จ๐ง ๐๐ง๐ฌ๐ญ๐๐ ๐ซ๐๐ฆ:- https://www.instagram.com/drgbhanuprakash
๐๐๐ผ๐ถ๐ป ๐ข๐๐ฟ ๐ง๐ฒ๐น๐ฒ๐ด๐ฟ๐ฎ๐บ ๐๐ต๐ฎ๐ป๐ป๐ฒ๐น ๐๐ฒ๐ฟ๐ฒ:- https://t.me/bhanuprakashdr
๐๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฏ๐ฒ ๐ง๐ผ ๐ ๐ ๐ ๐ฎ๐ถ๐น๐ถ๐ป๐ด ๐๐ถ๐๐:- https://linktr.ee/DrGBhanuprakash
Cervical Cancer part 2 : Obstetrics and gynaecology Video lectures ( Medvizz app )
The incidence and prevalence of cervical cancer have decreased significantly due to effective screening measures and vaccine development.
Because screening detects very early changes in the cervical epithelium, most patients diagnosed with cervical cancer are asymptomatic.
The human papillomavirus (HPV) is the primary cause of cervical cancer.
HPV inhibits the tumor suppressor proteins Rb and p53, which affects progression from the G1 phase to the S phase in the cell cycle and allows rampant cell growth.
Cervical cancer is a carcinoma arising from the cervical epithelium, most often at the squamocolumnar junction where the squamous epithelium of the ectocervix transitions to the columnar epithelium of the endocervix.
The Pap test is an important screening tool for cervical cancer.
Results are graded as LSIL, HSIL, or ASCUS. Biopsy specimens are graded histologically according to depth and are reported with CIN grades.
The HPV vaccine is a recombinant vaccine that protects against cervical cancer.
Treatment of cervical dysplasia and cancer varies by grade and stage and can include local treatment, surgery, or chemotherapy and radiation.
#cervicalcancer #obglectures #obgversion2.0 #neetpg #mbbs #nationalexitexam #reproductivepathology #usmlestep1
-
Category
No comments found